Nkarta, Inc.
NKTXNASDAQHealthcare● Active
$2.40
$-0.11(-4.38%)
Market Cap$171708859
P/E Ratio—
52W High$3.65
52W Low$1.63
Nkarta, Inc. (NKTX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NKTX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.37
Est. -$0.39 · +5.1%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
NKTX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$0.39 | — | — | — | — | — |
| ▲ Q2 FY2026 | May 12, 2026 | -$0.39 | -$0.37 | +5.1% | — | — | — |
| ▼ Q1 FY2026 | Mar 25, 2026 | -$0.32 | -$0.37 | -15.6% | — | — | — |
| ▲ Q4 FY2025 | Nov 10, 2025 | -$0.32 | -$0.29 | +9.4% | — | — | — |
| ▲ Q3 FY2025 | Aug 12, 2025 | -$0.37 | -$0.31 | +16.2% | — | — | — |
| ▲ Q2 FY2025 | May 14, 2025 | -$0.44 | -$0.43 | +2.3% | — | — | — |
| ▲ Q1 FY2025 | Mar 26, 2025 | -$0.41 | -$0.35 | +14.6% | — | — | — |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.37 | -$0.39 | -5.4% | — | — | — |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
-$0.39
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Beat
EPS Actual
-$0.37
EPS Est.
-$0.39
EPS Surpr.
+5.1%
Revenue
—
Q1 FY2026
Mar 25, 2026Miss
EPS Actual
-$0.37
EPS Est.
-$0.32
EPS Surpr.
-15.6%
Revenue
—
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
-$0.29
EPS Est.
-$0.32
EPS Surpr.
+9.4%
Revenue
—
Q3 FY2025
Aug 12, 2025Beat
EPS Actual
-$0.31
EPS Est.
-$0.37
EPS Surpr.
+16.2%
Revenue
—
Q2 FY2025
May 14, 2025Beat
EPS Actual
-$0.43
EPS Est.
-$0.44
EPS Surpr.
+2.3%
Revenue
—
Q1 FY2025
Mar 26, 2025Beat
EPS Actual
-$0.35
EPS Est.
-$0.41
EPS Surpr.
+14.6%
Revenue
—
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.39
EPS Est.
-$0.37
EPS Surpr.
-5.4%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.38 | $-0.38 | $-0.38 | 1 |
| Q3 FY2027 | $-0.39 | $-0.39 | $-0.39 | 1 |
| Q2 FY2027 | $-0.38 | $-0.38 | $-0.38 | 1 |
| Q1 FY2027 | $-0.40 | $-0.40 | $-0.40 | 1 |
| Q4 FY2026 | $-0.36 | $-0.36 | $-0.36 | 1 |
| Q3 FY2026 | $-0.39 | $-0.38 | $-0.37 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 12, 2026 | +5.1% | $3.18 | $3.28 | +3.14% |
| ▼ Q1 FY2026 | Mar 25, 2026 | -15.6% | $2.05 | $2.13 | +3.90% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +9.4% | $1.96 | $1.96 | +0.00% |
| ▲ Q3 FY2025 | Aug 12, 2025 | +16.2% | $2.01 | $1.96 | -2.49% |
| ▲ Q2 FY2025 | May 14, 2025 | +2.3% | $1.94 | $1.87 | -3.61% |
| ▲ Q1 FY2025 | Mar 26, 2025 | +14.6% | $1.43 | $1.37 | -4.20% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -5.4% | $3.35 | $3.27 | -2.39% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +30.6% | $5.07 | $4.97 | -1.97% |
Q2 FY2026+3.14%
Report Date
May 12, 2026
EPS Beat/Miss
+5.1%
Price Before
$3.18
Price After
$3.28
Q1 FY2026+3.90%
Report Date
Mar 25, 2026
EPS Beat/Miss
-15.6%
Price Before
$2.05
Price After
$2.13
Q4 FY2025+0.00%
Report Date
Nov 10, 2025
EPS Beat/Miss
+9.4%
Price Before
$1.96
Price After
$1.96
Q3 FY2025-2.49%
Report Date
Aug 12, 2025
EPS Beat/Miss
+16.2%
Price Before
$2.01
Price After
$1.96
Q2 FY2025-3.61%
Report Date
May 14, 2025
EPS Beat/Miss
+2.3%
Price Before
$1.94
Price After
$1.87
Q1 FY2025-4.20%
Report Date
Mar 26, 2025
EPS Beat/Miss
+14.6%
Price Before
$1.43
Price After
$1.37
Q4 FY2024-2.39%
Report Date
Nov 7, 2024
EPS Beat/Miss
-5.4%
Price Before
$3.35
Price After
$3.27
Q3 FY2024-1.97%
Report Date
Aug 13, 2024
EPS Beat/Miss
+30.6%
Price Before
$5.07
Price After
$4.97
Avg Beat Reaction-1.52%
Avg Miss Reaction+0.75%
Beat Rate6 / 8 quarters
Largest Move-4.20% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NKTX ends December
Nkarta, Inc. (NKTX) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.37 — beating the analyst consensus of $-0.39 by +5.1%. The next NKTX earnings date is expected around September 1, 2026.
Each quarter, investors track NKTX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NKTX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NKTX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NKTX earnings · 5 questionsNkarta, Inc.'s next earnings report is expected around September 1, 2026. NKTX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NKTX historically reports after market close (AMC).
NKTX earnings datewhen is NKTX earningsNKTX next earnings datewhen does NKTX report earningsNKTX earnings calendar
▸ Source: FMP · Nkarta, Inc. SEC filings · US GAAP · Nkarta, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026